197 related articles for article (PubMed ID: 29362007)
21. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
22. New transfer of care initiative of electronic referral from hospital to community pharmacy in England: a formative service evaluation.
Nazar H; Brice S; Akhter N; Kasim A; Gunning A; Slight SP; Watson NW
BMJ Open; 2016 Oct; 6(10):e012532. PubMed ID: 27742628
[TBL] [Abstract][Full Text] [Related]
23. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
24. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.
Gidman W; Cowley J
Int J Pharm Pract; 2013 Oct; 21(5):288-96. PubMed ID: 23418884
[TBL] [Abstract][Full Text] [Related]
25. Acceptance of a medication refill reminder service in German community pharmacy practice.
Breiholz S; -Mammen NG; Krueger K; Schaefer M; Schulz M
Pharmazie; 2019 Mar; 74(3):186-190. PubMed ID: 30961687
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service.
Wright D; Twigg M; Barton G; Thornley T; Kerr C
Int J Pharm Pract; 2015 Feb; 23(1):36-43. PubMed ID: 25409898
[TBL] [Abstract][Full Text] [Related]
27. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
Hu Y; Yao D; Ung COL; Hu H
Int J Chron Obstruct Pulmon Dis; 2020; 15():1863-1875. PubMed ID: 32821091
[TBL] [Abstract][Full Text] [Related]
28. Patients' use of GPs and community pharmacists in minor illness: a cross-sectional questionnaire-based study.
Hammond T; Clatworthy J; Horne R
Fam Pract; 2004 Apr; 21(2):146-9. PubMed ID: 15020382
[TBL] [Abstract][Full Text] [Related]
29. Practice change in community pharmacy: using change-management principles when implementing a pharmacy asthma management service in NSW, Australia.
Feletto E; Lui GW; Armour C; Saini B
Int J Pharm Pract; 2013 Feb; 21(1):28-37. PubMed ID: 23301531
[TBL] [Abstract][Full Text] [Related]
30. What do patients need to know? A study to assess patients' satisfaction with information about medicines.
Twigg MJ; Bhattacharya D; Clark A; Patel R; Rogers H; Whiteside H; Yaqoob M; Wright DJ
Int J Pharm Pract; 2016 Aug; 24(4):229-36. PubMed ID: 26875728
[TBL] [Abstract][Full Text] [Related]
31. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
Matheson C; Bond CM; Hickey F
Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
[TBL] [Abstract][Full Text] [Related]
32. Community pharmacy transition of care services and rural hospital readmissions: A case study.
Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
[TBL] [Abstract][Full Text] [Related]
33. A model for assessment and referral of clients with bowel symptoms in community pharmacies.
Sriram D; McManus A; Emmerton LM; Parsons RW; Jiwa M
Curr Med Res Opin; 2016; 32(4):661-7. PubMed ID: 26700973
[TBL] [Abstract][Full Text] [Related]
34. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
35. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
Maulavizada H; Emmerton L; Hattingh HL
BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
[TBL] [Abstract][Full Text] [Related]
36. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
37. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
[TBL] [Abstract][Full Text] [Related]
38. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
[TBL] [Abstract][Full Text] [Related]
39. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
40. Patient views about polypharmacy medication review clinics run by clinical pharmacists in GP practices.
Snell R; Langran T; Donyai P
Int J Clin Pharm; 2017 Dec; 39(6):1162-1165. PubMed ID: 29022166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
